Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Henry

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Clinical Therapeutics|October 14, 2003
Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetesRobert R Henry
Current Medical Research and Opinion|June 25, 2008
Evolving concepts of type 2 diabetes management with oral medications: new approaches to an old diseaseRobert R Henry
European Journal of Internal Medicine|July 8, 2009
Incretin therapies: effects beyond glycemic controlSunder Mudaliar, Robert R Henry
Current Diabetes Reports|February 7, 2004
Hyperglycemia with antipsychotic treatmentRoopa Sathyaprakash, Robert R Henry
Diabetes Technology & Therapeutics|July 10, 2007
Inhaled insulin in patients with asthma and chronic obstructive pulmonary diseaseSunder Mudaliar, Robert R Henry
Current Diabetes Reports|March 20, 2003
Preventing diabetes by treating aspects of the metabolic syndromeRoopa Sathyaprakash, Robert R Henry
Expert Opinion on Drug Safety|May 24, 2012
Thiazolidinedione safetyJacqueline Kung, Robert R Henry
The American Journal of Medicine|March 9, 2010
Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial functionSunder Mudaliar, Robert R Henry
The American Journal of Medicine|May 26, 2009
Incretin therapies: effects beyond glycemic controlSunder Mudaliar, Robert R Henry
Patient Preference and Adherence|August 16, 2016
Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributorsWilliam H Polonsky, Robert R Henry
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Clinical Therapeutics|October 14, 2003
Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetesRobert R Henry
Current Medical Research and Opinion|June 25, 2008
Evolving concepts of type 2 diabetes management with oral medications: new approaches to an old diseaseRobert R Henry
European Journal of Internal Medicine|July 8, 2009
Incretin therapies: effects beyond glycemic controlSunder Mudaliar, Robert R Henry
Current Diabetes Reports|February 7, 2004
Hyperglycemia with antipsychotic treatmentRoopa Sathyaprakash, Robert R Henry
Diabetes Technology & Therapeutics|July 10, 2007
Inhaled insulin in patients with asthma and chronic obstructive pulmonary diseaseSunder Mudaliar, Robert R Henry
Current Diabetes Reports|March 20, 2003
Preventing diabetes by treating aspects of the metabolic syndromeRoopa Sathyaprakash, Robert R Henry
Expert Opinion on Drug Safety|May 24, 2012
Thiazolidinedione safetyJacqueline Kung, Robert R Henry
The American Journal of Medicine|March 9, 2010
Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial functionSunder Mudaliar, Robert R Henry
The American Journal of Medicine|May 26, 2009
Incretin therapies: effects beyond glycemic controlSunder Mudaliar, Robert R Henry
Patient Preference and Adherence|August 16, 2016
Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributorsWilliam H Polonsky, Robert R Henry
Pageof 16